Jason E. Tester - Net Worth and Insider Trading

Jason E. Tester Net Worth

The estimated net worth of Jason E. Tester is at least $96 Million dollars as of 2024-11-10. Jason E. Tester is the Director, 10% Owner of Tarsus Pharmaceuticals Inc and owns about 1,949,331 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $96 Million. Details can be seen in Jason E. Tester's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason E. Tester has not made any transactions after 2020-10-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jason E. Tester

To

Jason E. Tester Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason E. Tester owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .

Click here to see the complete history of Jason E. Tester’s form 4 insider trades.

Insider Ownership Summary of Jason E. Tester

Ticker Comapny Transaction Date Type of Owner
TARS Tarsus Pharmaceuticals Inc 2020-10-20 director & 10 percent owner

Jason E. Tester Latest Holdings Summary

Jason E. Tester currently owns a total of 1 stock. Jason E. Tester owns 1,949,331 shares of Tarsus Pharmaceuticals Inc (TARS) as of October 20, 2020, with a value of $96 Million.

Latest Holdings of Jason E. Tester

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TARS Tarsus Pharmaceuticals Inc 2020-10-20 1,949,331 49.42 96,335,938

Holding Weightings of Jason E. Tester


Jason E. Tester Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason E. Tester has made a total of 1 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the acquisition of 171,875 shares on October 20, 2020, which cost Jason E. Tester around $3 Million.

Insider Trading History of Jason E. Tester

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason E. Tester Trading Performance

GuruFocus tracks the stock performance after each of Jason E. Tester's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason E. Tester is 92.93%. GuruFocus also compares Jason E. Tester's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason E. Tester within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jason E. Tester's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jason E. Tester

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.44 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Jason E. Tester Ownership Network

Ownership Network List of Jason E. Tester

No Data

Ownership Network Relation of Jason E. Tester

Insider Network Chart

Jason E. Tester Owned Company Details

What does Tarsus Pharmaceuticals Inc do?

Who are the key executives at Tarsus Pharmaceuticals Inc?

Jason E. Tester is the director & 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .

Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary

Over the past 18 months, Jason E. Tester made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 231,415 shares made by Bobak R. Azamian , a net sale of 11,909 shares made by Aziz Mottiwala , and a net sale of 12,792 shares made by Bryan Wahl .

In summary, during the past 3 months, insiders sold 35,000 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 35,000 shares. During the past 18 months, 322,965 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 312,459 shares.

Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tarsus Pharmaceuticals Inc Insider Transactions

No Available Data

Jason E. Tester Mailing Address

Above is the net worth, insider trading, and ownership report for Jason E. Tester. You might contact Jason E. Tester via mailing address: 15440 Laguna Canyon Road, Suite 160, Irvine Ca 92618.